Lycopus americanus
Bugleweed/Drug Interactions:
Antidiabetic agentsAntidiabetic agents: Theoretically, concomitant use of bugleweed may increase the risk of hypoglycemia.Hormonal agentsHormonal agents: Based on bugleweed's proposed hormone and antihormone-like actions (3; 4), concomitant use with hormonal agents is not recommended. Secondary sources and herbal tradition report bugleweed's anti-gonadotropic and anti-thyrotropic activity. Hypertensive agentsHypertensive agents: Based on secondary sources, bugleweed may have vasoconstricting properties. Based on a study of thyroxine treated hyperthyroid rats, Lycopus europaeus L. extracts may lower heart rate and blood pressure, alleviate cardiac hypertrophy, and reduce heart tissue beta-adrenoceptor density (5). Hypotensive agentsHypotensive agents: Based on secondary sources, bugleweed may have vasoconstricting properties. Based on a study of thyroxine treated hyperthyroid rats, Lycopus europaeus L. extracts may lower heart rate and blood pressure, alleviate cardiac hypertrophy, and reduce heart tissue beta-adrenoceptor density (5). SedativesSedatives: Based on historical use and expert opinion, bugleweed may have mild sedative effects (10). Thyroid hormonesThyroid hormones: In theory, concomitant use of bugleweed and thyroid hormones is contraindicated because bugleweed may reduce the effects of thyroid hormones (6; 9). Bugleweed/Herb/Supplement Interactions:
Hormonal herbs and supplementsHormonal herbs and supplements: Based on bugleweed's proposed hormone and antihormone-like actions (3; 4), concomitant use with hormonal agents is not recommended. Secondary sources and herbal tradition report bugleweed's anti-gonadotropic and anti-thyrotropic activity. Hypertensive agentsHypertensive agents: Based on secondary sources, bugleweed may have vasoconstricting properties. Based on a study of thyroxine treated hyperthyroid rats, Lycopus europaeus L. extracts may lower heart rate and blood pressure, alleviate cardiac hypertrophy, and reduce heart tissue beta-adrenoceptor density (5). HypoglycemicsHypoglycemics: Theoretically, concomitant use of bugleweed may increase the risk of hypoglycemia.Hypotensive agentsHypotensive agents: Based on secondary sources, bugleweed may have vasoconstricting properties. Based on a study of thyroxine treated hyperthyroid rats, Lycopus europaeus L. extracts may lower heart rate and blood pressure, alleviate cardiac hypertrophy, and reduce heart tissue beta-adrenoceptor density (5). SedativesSedatives: Based on historical use and expert opinion, bugleweed may have mild sedative effects (10). Thyroid agentsThyroid agents: In theory, concomitant use of bugleweed and thyroid suppressing herbs may have additive therapeutic effects (balm leaf, wild thyme plant) (6; 9). Bugleweed/Food Interactions:
Insufficient available evidence.Bugleweed/Lab Interactions:
Blood pressureBlood pressure: Based on secondary sources, bugleweed may have vasoconstricting properties. Based on a study of thyroxine treated hyperthyroid rats, Lycopus europaeus L. extracts may lower heart rate and blood pressure, alleviate cardiac hypertrophy, and reduce heart tissue beta-adrenoceptor density (5). Diagnostic proceduresDiagnostic procedures: Based on anecdote, bugleweed may interfere with diagnostic procedures using radioactive isotopes.Hormone levelsHormone levels: Based on secondary sources, bugleweed may have hormone and antihormone-like actions (3; 4), such as anti-gonadotropic and anti-thyrotropic activity, and may lower serum prolactin levels and inhibit peripheral deiodination of the thyroid hormone, T4. It may also have hypoglycemic activity. Serum glucoseSerum glucose: Theoretically, concomitant use of bugleweed may increase the risk of hypoglycemia.Thyroid testsThyroid tests: Based on historical use, bugleweed may improve thyroid function and test results in mildly hyperthyroid patients (6; 9). Bugleweed may interfere with nuclear imaging studies of the thyroid gland (thyroid uptake scan).